
Lenumlostat
CAS No. 2098884-52-5
Lenumlostat( —— )
Catalog No. M36314 CAS No. 2098884-52-5
Lenumlostat is an orally available, selective and potent lysyl oxidase-like protein 2 (LOXL2) inhibitor with inhibitory effects on hLOXL2, hLOXL3 and LOXL2 for the study of fibrotic diseases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 299 | Get Quote |
![]() ![]() |
5MG | 472 | Get Quote |
![]() ![]() |
10MG | 710 | Get Quote |
![]() ![]() |
25MG | 1371 | Get Quote |
![]() ![]() |
50MG | 2134 | Get Quote |
![]() ![]() |
100MG | 2988 | Get Quote |
![]() ![]() |
500MG | 6003 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLenumlostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionLenumlostat is an orally available, selective and potent lysyl oxidase-like protein 2 (LOXL2) inhibitor with inhibitory effects on hLOXL2, hLOXL3 and LOXL2 for the study of fibrotic diseases.
-
DescriptionLenumlostat is an orally available, selective and potent lysyl oxidase-like protein 2 (LOXL2) inhibitor with inhibitory effects on hLOXL2, hLOXL3 and LOXL2 for the study of fibrotic diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetMonoamine Transporter
-
RecptorMonoamine Oxidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2098884-52-5
-
Formula Weight399.34
-
Molecular FormulaC18H17F4N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C=1N=C(C(F)(F)F)C=C(CN)C1)C2=CC(C(=O)N3C[C@@H](F)[C@H](O)C3)=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Lenumlostat
Lenumlostat is an orally available, selective and potent lysyl oxidase-like protein 2 (LOXL2) inhibitor with inhibitory effects on hLOXL2, hLOXL3 and LOXL2 for the study of fibrotic diseases.
-
Vanoxerine
Vanoxerine (GBR-12909, I-893, Boxeprazine) is a highly potent inhibitor of dopamine uptake in vitro in tissue slices obtained from rat neostriatum with IC50 of 40-50 nM.
-
Edivoxetine
Edivoxetine (LY2216684) is a novel potent, selective norepinephrine reuptake inhibitor (NERI) being evaluated as adjunctive treatment for major depressive disorder (MDD).